Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Sanofi (SNY) Return on Sales (2016 - 2025)

Historic Return on Sales for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to 0.33%.

  • Sanofi's Return on Sales rose 3600.0% to 0.33% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.05%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.07% for FY2025, which is 700.0% up from last year.
  • According to the latest figures from Q4 2025, Sanofi's Return on Sales is 0.33%, which was up 3600.0% from 0.09% recorded in Q3 2025.
  • In the past 5 years, Sanofi's Return on Sales registered a high of 1.12% during Q4 2022, and its lowest value of 0.03% during Q4 2024.
  • Moreover, its 5-year median value for Return on Sales was 0.19% (2021), whereas its average is 0.21%.
  • As far as peak fluctuations go, Sanofi's Return on Sales plummeted by -11300bps in 2021, and later surged by 10900bps in 2022.
  • Over the past 5 years, Sanofi's Return on Sales (Quarter) stood at 0.03% in 2021, then skyrocketed by 4315bps to 1.12% in 2022, then tumbled by -101bps to 0.01% in 2023, then tumbled by -171bps to 0.03% in 2024, then skyrocketed by 1307bps to 0.33% in 2025.
  • Its last three reported values are 0.33% in Q4 2025, 0.09% for Q3 2025, and 0.14% during Q2 2025.